Back to Search
Start Over
A critique of the second consensus criteria for multiple system atrophy
- Source :
- Mov Disord, Movement disorders 34(7), 975-984 (2019). doi:10.1002/mds.27701
- Publication Year :
- 2019
- Publisher :
- Wiley, 2019.
-
Abstract
- © 2019 International Parkinson and Movement Disorder Society<br />Multiple system atrophy (MSA) is an adult-onset progressive neurodegenerative disorder that manifests clinically with autonomic failure, parkinsonism, and ataxia in any combination. Oligodendroglial cytoplasmatic inclusions consisting of misfolded α-synuclein are a pathological hallmark of disease. The clinical diagnosis of MSA is typically delayed as a result of incomplete or nonspecific manifestations during early disease stages. Quinn first published diagnostic criteria for MSA in 1989. Since then, the first consensus criteria in 1998 and their revision in 2008 have been widely accepted as diagnostic guidelines for MSA.
- Subjects :
- Pediatrics
medicine.medical_specialty
Consensus
health care facilities, manpower, and services
Treatment outcome
education
MEDLINE
Consensus criteria
therapeutic use [Levodopa]
Article
Levodopa
03 medical and health sciences
0302 clinical medicine
Atrophy
stomatognathic system
030225 pediatrics
mental disorders
MSA
Medicine
Humans
Genetic Predisposition to Disease
ddc:610
health care economics and organizations
business.industry
Multiple System Atrophy
medicine.disease
multiple system atrophy criteria
3. Good health
nervous system diseases
Treatment Outcome
diagnosis [Multiple System Atrophy]
nervous system
Neurology
drug therapy [Multiple System Atrophy]
genetics [Multiple System Atrophy]
Neurology (clinical)
business
030217 neurology & neurosurgery
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Mov Disord, Movement disorders 34(7), 975-984 (2019). doi:10.1002/mds.27701
- Accession number :
- edsair.doi.dedup.....5f83406f5f76021712d3ade7ae64aa79
- Full Text :
- https://doi.org/10.1002/mds.27701